Jayeshkumar S. Patel

Internal Medicine
550 Summit Ave
Jersey City,, NJ 07306

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications

Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas.

Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas.

Journal: Cancer research
Published: August 15, 2021

Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway.

Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway.

Journal: EBioMedicine
Published: December 18, 2017

Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma.

Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma.

Journal: Cancer research
Published: July 05, 2017

Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients.

Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients.

Journal: Clinical epigenetics
Published: March 22, 2016

Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.

Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.

Journal: Oncotarget
Published: July 22, 2015

Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas.

Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas.

Journal: Blood
Published: May 25, 2015
Showing 1-6 of 6

Last Updated: 09/26/2026